{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:15:21Z","timestamp":1780571721540,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13760-021-01647-9","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T17:02:23Z","timestamp":1617987743000},"page":"1187-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings"],"prefix":"10.1007","volume":"122","author":[{"given":"Masoume","family":"Nazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Bazrafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-5014","authenticated-orcid":false,"given":"Amin","family":"Abolhasani Foroughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"issue":"1","key":"1647_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","volume":"85","author":"M Absinta","year":"2015","unstructured":"Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC et al (2015) Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 85(1):18\u201328","journal-title":"Neurology"},{"key":"1647_CR2","first-page":"1","volume":"41","author":"R Bergamaschi","year":"2019","unstructured":"Bergamaschi R, Monti MC, Trivelli L, Introcaso VP, Mallucci G, Borrelli P et al (2019) Increased prevalence of multiple sclerosis and clusters of different disease risk in Northern Italy. Neurol Sci 41:1\u20137","journal-title":"Neurol Sci"},{"issue":"4","key":"1647_CR3","doi-asserted-by":"publisher","first-page":"e0231145","DOI":"10.1371\/journal.pone.0231145","volume":"15","author":"R Hashemi","year":"2020","unstructured":"Hashemi R, Hosseini-Asl SS, Arefhosseini SR, Morshedi M (2020) The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives. PLoS ONE 15(4):e0231145","journal-title":"PLoS ONE"},{"issue":"9","key":"1647_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1468-1331.2008.02241.x","volume":"15","author":"Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, Group L","year":"2008","unstructured":"Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, Group L (2008) Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 15(9):916\u2013921","journal-title":"Eur J Neurol"},{"issue":"4","key":"1647_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jocn.2007.02.090","volume":"15","author":"FB Aksungar","year":"2008","unstructured":"Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U (2008) Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci 15(4):393\u2013397","journal-title":"J Clin Neurosci"},{"issue":"4","key":"1647_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5539\/gjhs.v8n4p253","volume":"8","author":"A Nikseresht","year":"2016","unstructured":"Nikseresht A, Salehi H, Foroughi AA, Nazeri M (2016) Association between urinary symptoms and urinary tract infection in patients with multiple sclerosis. Glob J Health Sci 8(4):253","journal-title":"Glob J Health Sci"},{"issue":"9","key":"1647_CR7","doi-asserted-by":"publisher","first-page":"e54417","DOI":"10.1371\/journal.pone.0075021","volume":"8","author":"T Holm\u00f8y","year":"2013","unstructured":"Holm\u00f8y T, L\u00f8ken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H et al (2013) Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. PLoS ONE 8(9):e54417","journal-title":"PLoS ONE"},{"issue":"2","key":"1647_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1471-4159.2006.04232.x","volume":"100","author":"JL McQualter","year":"2007","unstructured":"McQualter JL, Bernard CC (2007) Multiple sclerosis: a battle between destruction and repair. J Neurochem 100(2):295\u2013306","journal-title":"J Neurochem"},{"issue":"2","key":"1647_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"key":"1647_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtemb.2019.05.011","volume":"55","author":"HO Do\u011fan","year":"2019","unstructured":"Do\u011fan HO, Yildiz \u00d6K (2019) Serum NADPH oxidase concentrations and the associations with iron metabolism in relapsing remitting multiple sclerosis. J Trace Elem Med Biol 55:39\u201343","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"1647_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"key":"1647_CR12","doi-asserted-by":"crossref","unstructured":"Foroughi AA, Zare N, Saeedi-Moghadam M, Zeinali-Rafsanjani B, Nazeri M (2021) Correlation between contrast enhanced plaques and plaque diffusion restriction and their signal intensities in FLAIR images in patients who admitted with acute symptoms of multiple sclerosis. J Med Imag Radiat Sci","DOI":"10.1016\/j.jmir.2020.12.001"},{"issue":"2","key":"1647_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1474-4422(18)30451-4","volume":"18","author":"M Filippi","year":"2019","unstructured":"Filippi M, Br\u00fcck W, Chard D, Fazekas F, Geurts JJ, Enzinger C et al (2019) Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 18(2):198\u2013210","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"1647_CR14","first-page":"S1","volume":"55","author":"S \u00d6merhoca","year":"2018","unstructured":"\u00d6merhoca S, Akka\u015f SY, \u0130\u00e7en NK (2018) Multiple sclerosis: diagnosis and differential diagnosis. Arch Neuropsych 55(Suppl 1):S1","journal-title":"Arch Neuropsych"},{"issue":"6","key":"1647_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s004150170158","volume":"248","author":"G Giovannoni","year":"2001","unstructured":"Giovannoni G, Miller D, Losseff N, Sailer M, Lewellyn-Smith N, Thompson A et al (2001) Serum inflammatory markers and clinical\/MRI markers of disease progression in multiple sclerosis. J Neurol 248(6):487\u2013495","journal-title":"J Neurol"},{"issue":"4","key":"1647_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1971400916678224","volume":"30","author":"A Abolhasani Foroughi","year":"2017","unstructured":"Abolhasani Foroughi A, Salahi R, Nikseresht A, Heidari H, Nazeri M, Khorsand A (2017) Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis. Neuroradiol J 30(4):347\u2013351","journal-title":"Neuroradiol J"},{"key":"1647_CR17","volume-title":"Adams and Victor\u2019s principles of neurology","author":"AH Ropper","year":"2019","unstructured":"Ropper AH, Samuels MA, Klein J, Prasad S (2019) Adams and Victor\u2019s principles of neurology. McGraw-Hill Education, New York"},{"issue":"4","key":"1647_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46(4):907\u2013911","journal-title":"Neurology"},{"issue":"1","key":"1647_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ane.12667","volume":"135","author":"M V\u00e5gberg","year":"2017","unstructured":"V\u00e5gberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y et al (2017) Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society. Acta Neurol Scand 135(1):17\u201324","journal-title":"Acta Neurol Scand"},{"key":"1647_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fimmu.2018.00457","volume":"9","author":"MJ Hossain","year":"2018","unstructured":"Hossain MJ, Morandi E, Tanasescu R, Frakich N, Caldano M, Onion D et al (2018) The Soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker. Front Immunol 9:457","journal-title":"Front Immunol"},{"issue":"3\u20134","key":"1647_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/NIB-170121","volume":"6","author":"M Farrokhi","year":"2017","unstructured":"Farrokhi M, Jahanbani-Ardakani H, Eskandari N, Shaygannejad V, Ghafari S (2017) Cerebrospinal fluid and serum markers of inflammation in patients with multiple sclerosis. Adv Neuroimmune Biol 6(3\u20134):149\u2013152","journal-title":"Adv Neuroimmune Biol"},{"key":"1647_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuroscience.2014.01.048","volume":"266","author":"C Polachini","year":"2014","unstructured":"Polachini C, Spanevello R, Casali E, Zanini D, Pereira L, Martins C et al (2014) Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis. Neuroscience 266:266\u2013274","journal-title":"Neuroscience"},{"issue":"4","key":"1647_CR23","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s12035-016-9860-z","volume":"54","author":"SR Oliveira","year":"2017","unstructured":"Oliveira SR, Kallaur AP, Reiche EM, Kaimen-Maciel DR, Panis C, Lozovoy MAB et al (2017) Albumin and protein oxidation are predictors that differentiate relapsing-remitting from progressive clinical forms of multiple sclerosis. Mol Neurobiol 54(4):2961\u20132968","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1647_CR24","first-page":"e82134","volume":"16","author":"A Abolhasani Foroughi","year":"2018","unstructured":"Abolhasani Foroughi A, Saeedi-Moghadam M, Zeinali-Rafsanjani B, Nazeri M (2018) Comparison between T2, STIR and PSIR sequences, for detection of cervical cord MS plaques. Iran J Radiol 16(3):e82134","journal-title":"Iran J Radiol"},{"key":"1647_CR25","first-page":"45","volume-title":"Gadolinium enhancing lesions in multiple sclerosis","author":"MA Sahraian","year":"2007","unstructured":"Sahraian MA, Radue E-W (2007) Gadolinium enhancing lesions in multiple sclerosis. Springer, MRI Atlas of MS Lesions, pp 45\u201374"},{"issue":"19","key":"1647_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1212\/WNL.0b013e3182553bd2","volume":"78","author":"Z Campbell","year":"2012","unstructured":"Campbell Z, Sahm D, Donohue K, Jamison J, Davis M, Pellicano C et al (2012) Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis. Neurology 78(19):1493\u20131499","journal-title":"Neurology"},{"issue":"1","key":"1647_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2377-13-72","volume":"13","author":"C Cheng","year":"2013","unstructured":"Cheng C, Jiang Y, Chen X, Dai Y, Kang Z, Lu Z et al (2013) Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol 13(1):72","journal-title":"BMC Neurol"},{"key":"1647_CR28","unstructured":"Louis ED, Mayer SA, Rowland LP (2016) Merritt's neurology. p 607"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-021-01647-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T08:10:15Z","timestamp":1664093415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-021-01647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1007\/s13760-021-01647-9","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}